MAPT and cardiovascular disorder: In experimental as well as human models, olfactory dysfunction has been linked with the expression of the apolipoprotein e4 allele and of tau protein and amyloid-β deposits [20, 21]; all these findings, in turn, are associated with several adverse clinical outcomes, including cardiovascular diseases and Alzheimer's disease [20].